StockData

Allarity Therapeutics vs Quantum Cyber

ALLR and QUCY side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ALLR and QUCY compare

Quantum Cyber scores higher on the StockData Score (3 against 1 for Allarity Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricALLRQUCY
Size and price
Market cap$13.4M–
Share price$0.841$0.580
Change, 1 year−28.7%−60.3%
Change, 5 years–−94.1%
Beta (5Y)1.462.15
Employees83
StockData Score
Total score13 (better)
Valuation score00
Growth score01 (better)
Performance score01 (better)
Health score11
Dividend score00
Valuation
P/B3.8×–
Growth
Revenue growth (TTM)–−39.9%
Revenue growth, 5Y average–1.7%
Profitability
Gross margin–72.6%
Operating margin–−3005%
Net margin–−3018%
FCF margin–−2045%
Return on equity−157%−141% (better)
Return on invested capital−957%−324% (better)
Financial health
Debt / equity5.90–
Interest coverage−10.1× (better)−43.2×
Current ratio1.115.56 (better)
Altman Z-score−6.65–
Piotroski F-score4 (better)2
Dividends and buybacks
Buyback yield6.6%–
Shareholder yield6.6%–
Ownership
Held by institutions8.1%2.4%
Held by insiders6.3%–
Insider net buying, 12 months–$0
Short interest, % of float1.5%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.